Literature DB >> 29076941

Newly Acquired Infection With Multidrug-Resistant HIV-1 in a Patient Adherent to Preexposure Prophylaxis.

Martin Markowitz1, Howard Grossman, Peter L Anderson, Robert Grant, Monica Gandhi, Howard Horng, Hiroshi Mohri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29076941      PMCID： PMC5792163          DOI： 10.1097/QAI.0000000000001534

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  21 in total

1.  Transmitted drug resistance and phylogenetic relationships among acute and early HIV-1-infected individuals in New York City.

Authors:  Delivette Castor; Andrea Low; Teresa Evering; Sharon Karmon; Brandi Davis; Amir Figueroa; Melissa LaMar; Donald Garmon; Saurabh Mehandru; Martin Markowitz
Journal:  J Acquir Immune Defic Syndr       Date:  2012-09-01       Impact factor: 3.731

2.  Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study.

Authors:  Robert M Grant; Peter L Anderson; Vanessa McMahan; Albert Liu; K Rivet Amico; Megha Mehrotra; Sybil Hosek; Carlos Mosquera; Martin Casapia; Orlando Montoya; Susan Buchbinder; Valdilea G Veloso; Kenneth Mayer; Suwat Chariyalertsak; Linda-Gail Bekker; Esper G Kallas; Mauro Schechter; Juan Guanira; Lane Bushman; David N Burns; James F Rooney; David V Glidden
Journal:  Lancet Infect Dis       Date:  2014-07-22       Impact factor: 25.071

3.  Multidrug-Resistant HIV-1 Infection despite Preexposure Prophylaxis.

Authors:  David C Knox; Peter L Anderson; P Richard Harrigan; Darrell H S Tan
Journal:  N Engl J Med       Date:  2017-02-02       Impact factor: 91.245

4.  Association of age, baseline kidney function, and medication exposure with declines in creatinine clearance on pre-exposure prophylaxis: an observational cohort study.

Authors:  Monica Gandhi; David V Glidden; Kenneth Mayer; Mauro Schechter; Susan Buchbinder; Beatriz Grinsztejn; Sybil Hosek; Martin Casapia; Juan Guanira; Linda-Gail Bekker; Alexander Louie; Howard Horng; Leslie Z Benet; Albert Liu; Robert M Grant
Journal:  Lancet HIV       Date:  2016-08-31       Impact factor: 12.767

5.  Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men.

Authors:  Peter L Anderson; David V Glidden; Albert Liu; Susan Buchbinder; Javier R Lama; Juan Vicente Guanira; Vanessa McMahan; Lane R Bushman; Martín Casapía; Orlando Montoya-Herrera; Valdilea G Veloso; Kenneth H Mayer; Suwat Chariyalertsak; Mauro Schechter; Linda-Gail Bekker; Esper Georges Kallás; Robert M Grant
Journal:  Sci Transl Med       Date:  2012-09-12       Impact factor: 17.956

6.  Pharmacological Measures of Treatment Adherence and Risk of HIV Infection in the VOICE Study.

Authors:  James Y Dai; Craig W Hendrix; Barbra A Richardson; Cliff Kelly; Mark Marzinke; Z Mike Chirenje; Jeanne M Marrazzo; Elizabeth R Brown
Journal:  J Infect Dis       Date:  2015-06-29       Impact factor: 5.226

7.  Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.

Authors:  Michael C Thigpen; Poloko M Kebaabetswe; Lynn A Paxton; Dawn K Smith; Charles E Rose; Tebogo M Segolodi; Faith L Henderson; Sonal R Pathak; Fatma A Soud; Kata L Chillag; Rodreck Mutanhaurwa; Lovemore Ian Chirwa; Michael Kasonde; Daniel Abebe; Evans Buliva; Roman J Gvetadze; Sandra Johnson; Thom Sukalac; Vasavi T Thomas; Clyde Hart; Jeffrey A Johnson; C Kevin Malotte; Craig W Hendrix; John T Brooks
Journal:  N Engl J Med       Date:  2012-07-11       Impact factor: 91.245

8.  Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.

Authors:  Jared M Baeten; Deborah Donnell; Patrick Ndase; Nelly R Mugo; James D Campbell; Jonathan Wangisi; Jordan W Tappero; Elizabeth A Bukusi; Craig R Cohen; Elly Katabira; Allan Ronald; Elioda Tumwesigye; Edwin Were; Kenneth H Fife; James Kiarie; Carey Farquhar; Grace John-Stewart; Aloysious Kakia; Josephine Odoyo; Akasiima Mucunguzi; Edith Nakku-Joloba; Rogers Twesigye; Kenneth Ngure; Cosmas Apaka; Harrison Tamooh; Fridah Gabona; Andrew Mujugira; Dana Panteleeff; Katherine K Thomas; Lara Kidoguchi; Meighan Krows; Jennifer Revall; Susan Morrison; Harald Haugen; Mira Emmanuel-Ogier; Lisa Ondrejcek; Robert W Coombs; Lisa Frenkel; Craig Hendrix; Namandjé N Bumpus; David Bangsberg; Jessica E Haberer; Wendy S Stevens; Jairam R Lingappa; Connie Celum
Journal:  N Engl J Med       Date:  2012-07-11       Impact factor: 91.245

9.  Human immunodeficiency virus reverse transcriptase and protease sequence database.

Authors:  Soo-Yon Rhee; Matthew J Gonzales; Rami Kantor; Bradley J Betts; Jaideep Ravela; Robert W Shafer
Journal:  Nucleic Acids Res       Date:  2003-01-01       Impact factor: 16.971

10.  Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.

Authors:  Sheena McCormack; David T Dunn; Monica Desai; David I Dolling; Mitzy Gafos; Richard Gilson; Ann K Sullivan; Amanda Clarke; Iain Reeves; Gabriel Schembri; Nicola Mackie; Christine Bowman; Charles J Lacey; Vanessa Apea; Michael Brady; Julie Fox; Stephen Taylor; Simone Antonucci; Saye H Khoo; James Rooney; Anthony Nardone; Martin Fisher; Alan McOwan; Andrew N Phillips; Anne M Johnson; Brian Gazzard; Owen N Gill
Journal:  Lancet       Date:  2015-09-09       Impact factor: 79.321
View more
  31 in total

Review 1.  Drug Resistance During HIV Pre-Exposure Prophylaxis.

Authors:  Kevin M Gibas; Polly van den Berg; Victoria E Powell; Douglas S Krakower
Journal:  Drugs       Date:  2019-04       Impact factor: 9.546

2.  Acquisition of tenofovir-susceptible, emtricitabine-resistant HIV despite high adherence to daily pre-exposure prophylaxis: a case report.

Authors:  Stephanie E Cohen; Darpun Sachdev; Sulggi A Lee; Susan Scheer; Oliver Bacon; Miao-Jung Chen; Hideaki Okochi; Peter L Anderson; Mary F Kearney; Susa Coffey; Hyman Scott; Robert M Grant; Diane Havlir; Monica Gandhi
Journal:  Lancet HIV       Date:  2018-11-29       Impact factor: 12.767

3.  Development and validation of an assay to analyze atazanavir in human hair via liquid chromatography/tandem mass spectrometry.

Authors:  Nhi Phung; Karen Kuncze; Hideaki Okochi; Alexander Louie; Leslie Z Benet; Igho Ofokotun; David W Haas; Judith S Currier; Tariro D Chawana; Anandi N Sheth; Peter Bacchetti; Monica Gandhi; Howard Horng
Journal:  Rapid Commun Mass Spectrom       Date:  2018-03-15       Impact factor: 2.419

Review 4.  Update on HIV Preexposure Prophylaxis: Effectiveness, Drug Resistance, and Risk Compensation.

Authors:  Victoria E Powell; Kevin M Gibas; Joshua DuBow; Douglas S Krakower
Journal:  Curr Infect Dis Rep       Date:  2019-06-21       Impact factor: 3.725

5.  Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trial.

Authors:  Raphael J Landovitz; Sue Li; Joseph J Eron; Beatriz Grinsztejn; Halima Dawood; Albert Y Liu; Manya Magnus; Mina C Hosseinipour; Ravindre Panchia; Leslie Cottle; Gordon Chau; Paul Richardson; Mark A Marzinke; Susan H Eshleman; Ryan Kofron; Adeola Adeyeye; David Burns; Alex R Rinehart; David Margolis; Myron S Cohen; Marybeth McCauley; Craig W Hendrix
Journal:  Lancet HIV       Date:  2020-06-01       Impact factor: 12.767

Review 6.  Approaches to Objectively Measure Antiretroviral Medication Adherence and Drive Adherence Interventions.

Authors:  Matthew A Spinelli; Jessica E Haberer; Peter R Chai; Jose Castillo-Mancilla; Peter L Anderson; Monica Gandhi
Journal:  Curr HIV/AIDS Rep       Date:  2020-08       Impact factor: 5.071

Review 7.  Review of Real-World Implementation Data on Emtricitabine-Tenofovir Disoproxil Fumarate as HIV Pre-exposure Prophylaxis in the United States.

Authors:  Jessica L Adams; Karishma Shelley; Melanie R Nicol
Journal:  Pharmacotherapy       Date:  2019-04-01       Impact factor: 4.705

8.  Maximizing the Benefits of HIV Preexposure Prophylaxis.

Authors:  Susan P Buchbinder
Journal:  Top Antivir Med       Date:  2018-04

9.  Seroconversion on preexposure prophylaxis: a case report with segmental hair analysis for timed adherence determination.

Authors:  Joshua T Thaden; Monica Gandhi; Hideaki Okochi; Christopher B Hurt; Mehri S McKellar
Journal:  AIDS       Date:  2018-06-01       Impact factor: 4.177

Review 10.  Adherence Measurements in HIV: New Advancements in Pharmacologic Methods and Real-Time Monitoring.

Authors:  Jose R Castillo-Mancilla; Jessica E Haberer
Journal:  Curr HIV/AIDS Rep       Date:  2018-02       Impact factor: 5.071
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.